First Level Socio-geriatric Evaluation: ESOGER Databank

Study Overview
=================
Brief Summary
-----------------
Coronavirus disease 2019 (COVID-19) is an infectious disease. Physical distancing is one of the most effective ways to reduce the spread of COVID-19, but this key prevention intervention may have adverse consequences on older adults living at home. Screening older adults living at home and at risk for adverse consequences of physical and social distancing is, therefore, a priority in order to prevent their occurrence. ESOGER (Evaluation Social et GERiatrique) is a clinical tool designed to: 1) screen the risk-levels for adverse consequences related to COVID-19 physical distancing and 2) to continue appropriate preventive interventions in older adults living at home including frail older patients and older community dwellers. Experience cumulated during the past two weeks revealed that ESOGER could be improved, in order to be more effective and efficient for the prevention of adverse consequences related to COVID-19 physical distancing. This improvement is based on two key components: 1) Comments of Montreal ESOGER users and 2) Analysis of data. Because at this time no information is saved and stored, there is a need to save and store ESOGER information and create the ESOGER databank.

Official Title
-----------------
First Level Socio-geriatric Evaluation in Period of Physical and Social Distancing in Frail Older Patients and Older Community Dwellers: ESOGER Databank

Conditions
-----------------
Frailty, COVID, Social Isolation, Anxiety

Intervention / Treatment
-----------------
* Other: ESOGER


Participation Criteria
=================
Eligibility Criteria
-----------------
The inclusion criteria are: Older (i.e., 70-years-old and over) adults OR caregiver living at home with an adult answering to inclusion criteria Living and staying at home because of physical and social distancing Understanding and writing the different languages of the recruitment centre (i.e., French, English, Chinese.) Agree to participate in the study The exclusion criteria are: A concomitant participation to another medical trial Living in semi-autonomous residence or CHSLD

Ages Eligible for Study
-----------------
Minimum Age: 70 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Older patients / community dwellers<br>The inclusion criteria are: Older (i.e., 70-years-old and over) adults OR caregiver living at home with an adult answering to inclusion criteria Living and staying at home because of physical and social distancing Understanding and writing the different languages of the recruitment centre (i.e., French, English, Chinese.) Agree to participate in the study The exclusion criteria are: A concomitant participation to another medical trial Living in semi-autonomous residence or CHSLD | Other: ESOGER<br>* Questionnaire<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| COVID-19 symptoms | presence or not of fever, cough and shortness of breath (binary question) | 1 day | 
| issues related to medication and food delivery and access to home care | presence or not of a rupture of access to food, medication and home care (binary question) | 1 day | 
| physical frailty | Questionnaire Emergency Room Evaluation and Recommandation (ER2), score from 0 = no risk of frailty to 14 = high risk of frailty) | 1 day | 
| psychological frailty | anxiety Verbal analogic scale, score from 0 = no anxiety to 10 = extremely anxious) | 1 day | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Caregiver burden | Zarit scale, score from 0 = no caregiver burden to 16 = high caregiver burden) | 1 day |